UNSPSC 51332510: Lenperone

This classification denotes an antipsychotic agent with the molecular formula C22H23F2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 13P4GX22ES chemically known as 1-butanone, 4-(4-(4-fluorobenzoyl)-1-piperidinyl)-1-(4-fluorophenyl)- but generally known as lenperone, which bears US NIH Compound Identifier 32593. European Medicines Agency schedules Lenperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08434MIG.

UNSPSC 51332510 Lenperone, a Commodity code, encompasses pharmaceutical products including naloxone and related drug-intervention systems that state and local governments procure to support community health and emergency response initiatives. The code captures the purchase of finished pharmaceutical goods and medical countermeasures distributed through public health channels, typically in bulk quantities with recurring annual demand. Issuing bodies under this code include county health departments and public health authorities operating community health programs and emergency response services.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) in June 2026 for the annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option, and vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify enrollment, and specified insurance coverage. The procurement indicates potential FEMA funding and introduces corresponding federal compliance obligations. Recent state and local activity under this code centers in Florida, though the sparse opportunity record suggests limited ongoing solicitation volume under this specific UNSPSC classification at present.